Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://ellabrwa713623.madmouseblog.com/19658586/trelaglutide-exploring-a-new-option-for-chronic-diseases